These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 39034402)

  • 1. PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression.
    Lee YF; Phua CZJ; Yuan J; Zhang B; Lee MY; Kannan S; Chiu YHJ; Koh CWQ; Yap CK; Lim EKH; Chen J; Lim Y; Lee JJH; Skanderup AJ; Wang Z; Zhai W; Tan NS; Verma CS; Tay Y; Tan DSW; Tam WL
    Genome Med; 2024 Jul; 16(1):91. PubMed ID: 39034402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.
    Ho JS; Di Tullio F; Schwarz M; Low D; Incarnato D; Gay F; Tabaglio T; Zhang J; Wollmann H; Chen L; An O; Chan THM; Hall Hickman A; Zheng S; Roudko V; Chen S; Karz A; Ahmed M; He HH; Greenbaum BD; Oliviero S; Serresi M; Gargiulo G; Mann KM; Hernando E; Mulholland D; Marazzi I; Wee DKB; Guccione E
    Elife; 2021 Jun; 10():. PubMed ID: 34075878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
    Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
    Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.
    Xu Y; Gao XD; Lee JH; Huang H; Tan H; Ahn J; Reinke LM; Peter ME; Feng Y; Gius D; Siziopikou KP; Peng J; Xiao X; Cheng C
    Genes Dev; 2014 Jun; 28(11):1191-203. PubMed ID: 24840202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
    Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
    EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
    Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
    RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNPM protects against the dsRNA-mediated interferon response by repressing LINE-associated cryptic splicing.
    Zheng R; Dunlap M; Bobkov GOM; Gonzalez-Figueroa C; Patel KJ; Lyu J; Harvey SE; Chan TW; Quinones-Valdez G; Choudhury M; Le Roux CA; Bartels MD; Vuong A; Flynn RA; Chang HY; Van Nostrand EL; Xiao X; Cheng C
    Mol Cell; 2024 Jun; 84(11):2087-2103.e8. PubMed ID: 38815579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insights into the Roles of PARP4 and NAD
    Lodwick JE; Shen R; Erramilli S; Xie Y; Roganowicz K; Kossiakoff AA; Zhao M
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation.
    Zhu HE; Li T; Shi S; Chen DX; Chen W; Chen H
    J Exp Clin Cancer Res; 2021 Feb; 40(1):64. PubMed ID: 33573689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
    Han S; Cao D; Sha J; Zhu X; Chen D
    Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YTHDF1 Promotes Cyclin B1 Translation through m
    Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
    Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
    Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEPDC1B is a Novel Direct Target of B-Myb and Contributes to Malignant Progression and Immune Infiltration in Lung Adenocarcinoma.
    Zuo X; Wang D; Tao C; Dou X; Zhao Z; Zhang J; Huang S; Li Y; Zhang X; Bu Y; Wang Y
    Front Biosci (Landmark Ed); 2024 May; 29(6):204. PubMed ID: 38940035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways.
    Xu XC; He S; Zhou YQ; Liu CJ; Liu SQ; Peng W; Liu YX; Wei PP; Bei JX; Luo CL
    J Genet Genomics; 2021 Jul; 48(7):595-605. PubMed ID: 34274258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
    Sun X; Wang R; Tan M; Tian X; Meng J
    Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM.
    Ramesh N; Kour S; Anderson EN; Rajasundaram D; Pandey UB
    Acta Neuropathol Commun; 2020 Aug; 8(1):138. PubMed ID: 32811564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis.
    Liu S; Liu X; Yang Q; Zeng C; Hu G; Ren B
    J Pharm Pharmacol; 2024 Jul; 76(7):873-883. PubMed ID: 38698658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
    Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
    Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
    Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.